Induction of differentiation by 1α-hydroxyvitamin D5 in T47D human breast cancer cells and its interaction with vitamin D receptors

This publication has 23 references indexed in Scilit:

• Prevention of Preneoplastic Mammary Lesion Development by a Novel Vitamin D Analogue, 1 -Hydroxyvitamin D5
  JNCI Journal of the National Cancer Institute, 1997
• EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells
  The Journal of Steroid Biochemistry and Molecular Biology, 1993
• Effects of synthetic vitamin d analogues on breast cancer cell proliferation in vivo and in vitro
  Biochemical Pharmacology, 1992
• RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements
  Cell, 1991
• Topical calcipotriol treatment in advanced breast cancer
  The Lancet, 1991
• In vitro study of effects of 1,25 dihydroxyvitamin D3 on the morphology of human breast cancer cell line BT.20
  Differentiation, 1989
• POSSIBLE ROLE FOR VITAMIN D IN CONTROLLING BREAST CANCER CELL PROLIFERATION
  The Lancet, 1989
• Vitamin D Receptors: Nature and Function
  Annual Review of Nutrition, 1986
• Effect of 1 α-hydroxyvitamin D3 on metastasis of rat ascites hepatoma K-231
  British Journal of Cancer, 1984
• Synthesis of vitamin D5: Its biological activity relative to vitamins D3 and D2
  Archives of Biochemistry and Biophysics, 1979